Autopsy report · NCT02833701
Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
Cause of deathNo reason given
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 3 years before it stopped.
- 9 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- University of Nebraska
- Sponsor type
- University, hospital or other
- Conditions
- Glioblastoma; Glioma
- Interventions
- Ascorbic Acid; Bevacizumab; Laboratory Biomarker Analysis; Quality-of-Life Assessment
- Participants
- 9
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.